Skip to main content
. 2024 Nov 9;19:11611–11631. doi: 10.2147/IJN.S479697

Table 3.

Exosomes as Potential Biomarkers and Targets for Hematologic Malignancies

Hematologic Malignancies Exosomal Contents Exosomal Cargo Applications Ref
Acute myeloid leukemia miRNA miR-532 Biomarkers of acute myeloid leukemia [29]
Acute lymphoblastic leukemia miR-326 Biomarkers of acute lymphoblastic leukemia [119]
Diffuse large B-cell lymphoma miR-99a-5p and miR-125b-5p Biomarkers of diffuse large B-cell lymphoma [27]
Multiple myeloma miR-185-5p and miR-4741 Biomarkers for multiple myeloma [120]
Multiple myeloma miR-483-5p Biomarkers for multiple myeloma [121]
Multiple myeloma miR-451 Biomarkers for multiple myeloma [122]
Lymphoma miR-155 and miR-1246 Biomarkers for T-cell-associated lymphomas [118]
Lymphoma miR-200c and miR-141 Biomarkers for primary central nervous system lymphoma [28]
Lymphoma miR-4717-5p Potential targets for lymphoma [106]
Diffuse large B-cell lymphoma miR-107 Potential targets for Diffuse large B-cell lymphoma [30]
Multiple myeloma miR-21 Potential targets for multiple myeloma [123]
Acute myeloid leukemia miR-23b-5p Potential targets in acute myeloid leukemia [32]
Multiple myeloma circRNA circHNRNPU_603aa Biomarkers for multiple myeloma [124]
Chronic myelogenous leukemia Proteins Hsa-circ-0058493 Potential targets for chronic myelogenous leukemia [31]
Diffuse large B-cell lymphoma ENO2 Potential targets for Diffuse large B-cell lymphoma [125]